Literature DB >> 26479038

Possible Common Aetiology behind Maternal Preeclampsia and Congenital Heart Defects in the Child: a Cardiovascular Diseases in Norway Project Study.

Kristoffer Brodwall1,2, Elisabeth Leirgul1,3, Gottfried Greve4,2, Stein Emil Vollset1,5, Henrik Holmstrøm6, Grethe S Tell1,7, Nina Øyen1,8.   

Abstract

BACKGROUND: The aetiology of congenital heart defects (CHD) is mostly unknown, but maternal factors may modify the infant risk of CHD. We investigated the association between maternal preeclampsia and offspring risk of severe CHD in a nation-wide cohort study.
METHODS: Information on all births registered in the Medical Birth Registry of Norway, 1994-2009, was completed with information on CHD diagnoses from national health registries and the Cardiovascular Diseases in Norway Project (CVDNOR).
RESULTS: Among 914 703 singleton births without chromosomal abnormalities, 32 864 (3.6%) were born after a pregnancy with preeclampsia. The preeclampsia was diagnosed before the 34th week of pregnancy (early-onset preeclampsia) in 2618 (8.0% of preeclamptic pregnancies). CHDs were diagnosed in 10 691 infants; of these, 2473 had severe CHD. The risk of severe CHD was compared between births with and without maternal preeclampsia and estimated with binomial log-linear regression. When adjusting for year of birth, maternal age, parity, and pregestational diabetes, the risk ratio (RR) for severe CHD in offspring of mothers with any preeclampsia was 1.3 [95% confidence interval (CI) 1.1, 1.5], and in pregnancies with early-onset preeclampsia, the RR was 2.8 (95% CI 1.8, 4.4). The association between early-onset preeclampsia and specific types of severe CHD was stronger for atrioventricular septal defects (AVSD), with adjusted RR 13.5 (95% CI 6.8, 26.8).
CONCLUSIONS: Early-onset preeclampsia was strongly associated with infant risk of severe CHD, specifically; the risk of AVSD was 15-fold higher if the mother was diagnosed with early-onset preeclampsia, suggesting common aetiological factors for early-onset preeclampsia and erroneous fetal heart development.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  congenital heart defects; epidemiology; hypertension; pregnancy

Mesh:

Year:  2015        PMID: 26479038     DOI: 10.1111/ppe.12252

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  16 in total

1.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

2.  Fetal somatic growth trajectory differs by type of congenital heart disease.

Authors:  Kriti Puri; Carri R Warshak; Mounira A Habli; Amy Yuan; Rashmi D Sahay; Eileen C King; Allison Divanovic; James F Cnota
Journal:  Pediatr Res       Date:  2017-12-20       Impact factor: 3.756

3.  Soluble guanylate cyclase stimulation in late gestation does not mitigate asymmetric intrauterine growth restriction or cardiovascular risk induced by placental ischemia in the rat.

Authors:  Laura E Coats; Bhavisha A Bakrania; Daniel R Bamrick-Fernandez; Allison M Ariatti; Adam Z Rawls; Norma B Ojeda; Barbara T Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-19       Impact factor: 4.733

Review 4.  Clinical outcomes of hypertensive disorders in pregnancy in the offspring during perinatal period, childhood, and adolescence.

Authors:  Malamati Kanata; Eleni Liazou; Athanasia Chainoglou; Vasilios Kotsis; Stella Stabouli
Journal:  J Hum Hypertens       Date:  2021-05-13       Impact factor: 3.012

5.  Impact of Maternal-Fetal Environment on Mortality in Children With Single Ventricle Heart Disease.

Authors:  Jill J Savla; Mary E Putt; Jing Huang; Samuel Parry; Julie S Moldenhauer; Samantha Reilly; Olivia Youman; Jack Rychik; Laura Mercer-Rosa; J William Gaynor; Steven M Kawut
Journal:  J Am Heart Assoc       Date:  2022-01-11       Impact factor: 6.106

6.  The Role of Abnormal Placentation in Congenital Heart Disease; Cause, Correlate, or Consequence?

Authors:  Jennifer A Courtney; James F Cnota; Helen N Jones
Journal:  Front Physiol       Date:  2018-08-07       Impact factor: 4.566

7.  Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes.

Authors:  Shiliang Liu; K S Joseph; Wei Luo; Juan Andrés León; Sarka Lisonkova; Michiel Van den Hof; Jane Evans; Ken Lim; Julian Little; Reg Sauve; Michael S Kramer
Journal:  Circulation       Date:  2016-08-30       Impact factor: 29.690

Review 8.  Recent Advances in Placenta-Heart Interactions.

Authors:  Cheryl L Maslen
Journal:  Front Physiol       Date:  2018-06-14       Impact factor: 4.566

9.  Expression of miR-376 in blood of pregnant women with preeclampsia and its effect on 25-hydroxyvitamin D.

Authors:  Jinlan Li; Jiangdong Du; Zhan Wang; Chenghong Wang; Jianhua Bai; Su Zhang
Journal:  Exp Ther Med       Date:  2018-07-03       Impact factor: 2.447

10.  Profile of congenital heart disease in infants born following exposure to preeclampsia.

Authors:  Christopher S Yilgwan; Victor C Pam; Olukemi O Ige; Williams N Golit; Stephen Anzaku; Godwin E Imade; Gavou Yilgwan; Josiah T Mutihir; Atiene S Sagay; Augustine Odili; Ayuba I Zoakah; Fidelia Bode-Thomas; Melissa A Simon
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.